MetaCap

DexCom (DXCM) Stock Chart

NASDAQ: DXCMHealth CareMedical/Dental InstrumentsUSD

79.32-0.87 (-1.08%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

DXCM technical summary

DXCM is trading 5.5% below its 50-day simple moving average of $83.94 and 5.3% above its 200-day average of $75.32. The 50-day average is above the 200-day average, a configuration technical analysts associate with a longer-term uptrend. The 14-day Relative Strength Index (RSI) is 43.2, within the neutral 30 to 70 band.

Over the past year, the stock ranged from $56.72 (Apr 29, 2026) to $92.59 (Aug 24, 2026); the current price sits 63% of the way from the low to the high. Annualized 30-day volatility is 45.7%. Based on the last session's high, low and close, the classic pivot point is $79.88, with first resistance at $81.02 and first support at $78.19.

These indicators describe past price behavior for DexCom; they are not predictions.

Summary generated from market data by MetaCap's automated system. Methodology

Technical indicators

Beta
—
1Y high
92.59 (Aug 24)
1Y low
56.72 (Apr 29)
Last close
79.32

DXCM price performance

1 week

-4.81%

1 month

-1.17%

3 months

-14.10%

6 months

+10.01%

Year to date

+19.51%

1 year

+31.70%

3 years

-29.77%

5 years

-46.40%

DXCM price return, excluding dividends.

Moving averages

Simple and exponential moving averages
PeriodSimple (SMA)Exponential (EMA)
5-day81.14Price below80.75Price below
10-day81.17Price below81.24Price below
20-day81.49Price below81.79Price below
50-day83.94Price below82.79Price below
100-day83.18Price below81.44Price below
200-day75.32Price above76.20Price above

Moving averages are computed from daily closing prices over the past year. What is a moving average?

Pivot points

Classic pivot points
LevelPrice
Resistance 3 (R3)83.85
Resistance 2 (R2)82.71
Resistance 1 (R1)81.02
Pivot point79.88
Support 1 (S1)78.19
Support 2 (S2)77.05
Support 3 (S3)75.36

Classic floor-trader pivots from the last session's high, low and close. How pivot points work

Learn technical analysis